Key Points
Anheuser-BuschInBev raised its annualdividendby 9% on Thursday, though analysts warned investors may be disappointed by theabsence of anewsharebuybackand worse-than-expected U.S. sales...
That spree built it into a global beer behemoth, but also left it with debts of over $100 billion that it struggled to reduce as quickly as hoped, limiting itsability to return cash toshareholders...
Some investors may be disappointed thebuybackprogramme has not been renewed, Edward Mundy, analyst at Jefferies, wrote in a note.. James Edwardes Jones, an analyst at RBC Capital Markets, added that volume declines in the United States were also worse than expected, though overall the results were "good enough"...
ABInBev's sales in its hefty U.S. business have been hit by a consumer boycott of key U.S. brand Bud Light, knockingit off itstopspot as the best-selling U.S. beer...
ABInBevreported a 6.2% rise in fourth-quarter sales versus analysts' expectations of 6.1% in a consensus estimate provided by the company...
You might be interested in
AI-first strategy working for Infosys despite unresolved ethical, IPR issues, says Nilekani at AGM
28, Jun, 23Infosys grew in double digits across most industry segments and across major geographic markets in FY23, 26% in Europe and 12% in the US, said Nilekani
PharmEasy appoints Avendus to help raise $100 mn capital
09, Jun, 23Existing investors, largely led by Naspers, Temasek, CDPQ and TPG are finalising plans to put in around ₹250 crore into PharmEasy
OfBusiness to raise up to $200 mn, eyes $6 bn value
23, Nov, 23The Delhi-based B2B marketplace was last valued at $5 billion in 2021 when it raised $325 million from investors
Mamaearth eyes ₹2K cr pre-Diwali listing
20, Oct, 23Mamaearth plans IPO valued at $1.2 billion-$1.4 billion before Diwali